Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moosig

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Thorax|September 20, 2001
CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosisP Lamprecht, F Moosig, E Csernok, et al.
Annals of the Rheumatic Diseases|March 15, 2001
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitisP Lamprecht, F Moosig, A Gause, et al.
Arthritis and Rheumatism|June 3, 2008
Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosisS Wieczorek, B Hellmich, L Arning, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET studyF Moosig, N Czech, C Mehl, et al.
Clinical and Experimental Immunology|October 27, 2001
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosisK Steiner, F Moosig, E Csernok, et al.
Clinical Rheumatology|September 3, 2014
Association of ferritin antibodies with Takayasu arteritisK Große, T Witte, F Moosig, et al.
Arthritis and Rheumatism|April 22, 1999
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammationE Csernok, A Trabandt, A Müller, et al.
Clinical and Experimental Immunology|November 15, 2006
Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosusF Moosig, F Damm, A Knorr-Spahr, et al.
Clinical and Experimental Rheumatology|January 27, 2004
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associationsH Schultz, E Csernok, K Herlyn, et al.
Deutsche Medizinische Wochenschrift (1946)|October 22, 2014
[B-cell targeted therapy in patients with granulomatosis with polyangiitis and microscopic polyangiitis]F Moosig, P-M Aries, K de Groot, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Thorax|September 20, 2001
CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosisP Lamprecht, F Moosig, E Csernok, et al.
Annals of the Rheumatic Diseases|March 15, 2001
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitisP Lamprecht, F Moosig, A Gause, et al.
Arthritis and Rheumatism|June 3, 2008
Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosisS Wieczorek, B Hellmich, L Arning, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET studyF Moosig, N Czech, C Mehl, et al.
Clinical and Experimental Immunology|October 27, 2001
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosisK Steiner, F Moosig, E Csernok, et al.
Clinical Rheumatology|September 3, 2014
Association of ferritin antibodies with Takayasu arteritisK Große, T Witte, F Moosig, et al.
Arthritis and Rheumatism|April 22, 1999
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammationE Csernok, A Trabandt, A Müller, et al.
Clinical and Experimental Immunology|November 15, 2006
Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosusF Moosig, F Damm, A Knorr-Spahr, et al.
Clinical and Experimental Rheumatology|January 27, 2004
ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associationsH Schultz, E Csernok, K Herlyn, et al.
Deutsche Medizinische Wochenschrift (1946)|October 22, 2014
[B-cell targeted therapy in patients with granulomatosis with polyangiitis and microscopic polyangiitis]F Moosig, P-M Aries, K de Groot, et al.
Pageof 7